Contact UsInvestorsCareersMediaScienceContact Us
HomeNewsMOU Signing Ceremony in child healthcare between Pfizer Vietnam and the Vietnam Pediatrics Association. MOU Signing Ceremony in child healthcare between Pfizer Vietnam and the Vietnam Pediatrics Association. 

HANOI, May 26, 2023, Pfizer (Vietnam) Limited Company signed the  MoU with the Vietnam Pediatrics Association to enhance the capacity of healthcare professionals in the diagnosis and treatment of pediatrics in such as respiratory department, neonatology, emergency resuscitation, infectious diseases, surgery... in the period 2023-2026.



The signing ceremony marks a significant milestone for the long-term partnership between Vietnam Pediatrics Association and Pfizer in the advanced management of pediatric patient to make a positive impact on the community health care. The main purpose of this collaboration is to cooperate, support and strengthen the capacity of healthcare workers in the diagnosis and treatment of pediatric diseases, through interdisciplinary coordination and instruction on how to use antibiotics safely and effectively.

According to the United Nations Children's Fund (UNICEF), pneumonia, diarrhea and malaria were responsible for about 30% of global deaths among children under 5 years old in 2019.(1) In Vietnam, 33,000 children under 5 years old died from preventable diseases.(2) Remarkably, the World Health Organization (WHO) reveals that pneumonia is the leading cause of death in children under 5 years of age worldwide. This disease killed 740 180 children under the age of 5 in 2019, accounting for 14% of all deaths of children under 5 years old but 22% of all deaths in children aged 1 to 5 years.(3)

Associate Doctor Tran Minh Dien, the president of the Vietnam Pediatric Association at the ceremony

Associate Doctor Tran Minh Dien, the president of the Vietnam Pediatric Association said: “The COVID-19 pandemic has led to unpredictability in the disease model, becoming an objective factor in creating more difficulties in pediatric healthcare compared to pre-pandemic times. In the disease model in Vietnam, infectious diseases are top-ranked. In particular, respiratory and gastrointestinal infections, as well as seasonal epidemics, require attention in both prevention and treatment. Besides, non-communicable diseases are mentioned as challenges, such as congenital diseases, cancer, chronic kidney disease, liver disease, obesity, and injuries. These impose a burden not only on the patients but also on their families and society. So, it is important for us to know how resources can be allocated to ensure equitable, efficient, and high-quality pediatric healthcare.

Among the resource factors, the quality of human resources is the most vital in the current situation, specifically pediatric doctors and nurses. For that reason, the Vietnam Pediatric Association hopes to collaborate with organizations and institutions to enhance the knowledge, skills, and attitudes of pediatric doctors and nurses, aiming to further improve healthcare services for children in all regions of Vietnam. Through this partnership between the two parties, we hope to promote cooperation and effectively implement activities that strive for equity in healthcare, aiming to improve the health of Vietnamese children”.

Darrell Oh, General Director at Pfizer Vietnam, gives a speech at the ceremony.

Mr. Darrell Oh, General Director of Pfizer Vietnam said: “Today, infectious diseases are a global concern for public health and antibiotics are a primary area of focus for Pfizer. When it comes to pediatric health, capacity building for pediatric patients as well as the safe and effective application of antibiotics in treatment will help improve the quality of the health system. Pfizer commits to supporting the Vietnam Pediatrics Association on public health in general and pediatric health in detail. As one of the leading biopharmaceutical companies in the world, Pfizer has advantages in the fields of infections, oncology, rare diseases, immunology and inflammation, internal medicine, and cardiology, as well as vaccines. We have made relentless efforts to create breakthroughs that change patients' lives. With our global presence and scale, we strive to make differences to build a healthier future.”

Accordingly, Vietnam Pediatrics Association and Pfizer Vietnam signed a memorandum of understanding (MoU) to improve the capacity of healthcare professionals in the diagnosis and treatment of diseases in the field of pediatrics nationwide through many activities such as conference series, online training sessions. These activities are well-designed to provide up-to-date scientific information to health workers, with experienced local and foreign speakers to join.


  1. Childhood diseases, Accessed on May 15, 2023
  2. Tổng cục điều tra dân số năm 2019, Tổng cục thống kê.
  3. Pneumonia in children, Accessed on May 15, 2023

About Vietnam Pediatrics Association
The Vietnam Pediatrics Association is under Decision No. 111 -NV on April 29, 1961, of the Ministry of Home Affairs, with more than 100 healthcare professionals and pediatricians nationwide in the begining. The association has 8 specialized branches including: Vietnam Perinatal and Neonatal Association, Pediatric Respiratory Society, Pediatric Allergy Immunology, Pediatric Endocrinology - Metabolism - Genetics Society, Association of Pediatric Resuscitation - Emergency - Antitoxicity, Pediatric Gastroenterology Branch, Pediatric Oncology Branch, and local Pediatric Associations such as Hanoi, Ho Chi Minh City, Central. Over 60 years, Vietnam Pediatric Association has made significant contributions:
1. Gathering and developing pediatricians nationwide, building and developing pediatrics department, protecting, and enhancing children's healthcare, contributing to develop Vietnamese medicine.
2. Updating new knowledge; improving qualifications and skills, training, conducting scientific research;applying pediatric research results to members nationwide, helping to develop breadth and depth of Pediatrics department in Vietnam.
3. Developing and orientating children's healthcare protection strategies in the community, giving diagnosis and treatment protocols, application of knowledge and experience in the industry; as we as lowers the mortality rate and the incidence of common diseases among Vietnamese children in each historical period.
4. Providing active advises and critiques guidelines, policies, and strategies to protect children’s health.
5. Strengthening cooperation with domestic and foreign associations to enhance the prestige and responsibility of the Vietnam Pediatric Association nationally and globally..
Over 60 years of developing medicine in general and pediatric healthcare in Vietnam in detail, , the Vietnam Pediatrics Association has been increasingly developed and greatly contributed to protect the Vietnamese children’s health
To learn more information about the Vietnam Pediatric Association, please visit us at:

About Pfizer: Breakthroughs That Change Patients’ Lives 
At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products, including innovative medicines and vaccines. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as one of the world's premier innovative biopharmaceutical companies, we collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For more than 170 years, we have worked to make a difference for all who rely on us. We routinely post information that may be important to investors on our website at In addition, to learn more, please visit us on and follow us on Twitter at @Pfizer and @Pfizer News, LinkedIn, YouTube and like us on Facebook at

Disclosure Notice 
The information contained in this release is as of May 26, 2023. Pfizer assumes no obligation to update forward-looking statements contained in this release as the result of new information or future events or developments.

Media Contact
Minh Ha Ho
+84 987 530 219
[email protected] 

Careers News Health Care Pro Partners About UsYour Health    Our Science Media Pfizer Inc. Privacy Policy Terms of UseContact Us Business to Business Copyright © 2002- 2022 Pfizer Inc.